Cancer cells recognized as “foreign” by the immune system and initially targeted for destruction will often adapt by overexpressing PD-L1 and other checkpoint inhibitors to, in effect, mask themselves from the immune response thereby avoiding destruction. The gene discussed is CD274; the disease is cancer.